Valneva Non Current Liabilities Total from 2010 to 2025

VALN Stock  USD 11.58  0.01  0.09%   
Valneva SE Non Current Liabilities Total yearly trend continues to be very stable with very little volatility. Non Current Liabilities Total is likely to grow to about 214.4 M this year. During the period from 2010 to 2025, Valneva SE Non Current Liabilities Total quarterly data regression pattern had sample variance of 6669.3 T and median of  84,490,000. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2009-12-31
Previous Quarter
200.8 M
Current Value
160.5 M
Quarterly Volatility
67.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Valneva SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Valneva SE's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.6 M, Interest Expense of 25.2 M or Total Revenue of 96.9 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or PTB Ratio of 1.65. Valneva financial statements analysis is a perfect complement when working with Valneva SE Valuation or Volatility modules.
  
Build AI portfolio with Valneva Stock
Check out the analysis of Valneva SE Correlation against competitors.

Latest Valneva SE's Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Valneva SE ADR over the last few years. It is Valneva SE's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Valneva SE's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Valneva Non Current Liabilities Total Regression Statistics

Arithmetic Mean108,960,062
Geometric Mean74,732,433
Coefficient Of Variation74.95
Mean Deviation68,118,328
Median84,490,000
Standard Deviation81,665,919
Sample Variance6669.3T
Range271.5M
R-Value0.83
Mean Square Error2172.6T
R-Squared0.70
Significance0.000059
Slope14,309,996
Total Sum of Squares100039.8T

Valneva Non Current Liabilities Total History

2025214.4 M
2024204.2 M
2023182.3 M
2022124.2 M
2021277.8 M
2020195.9 M
201988.3 M

About Valneva SE Financial Statements

Valneva SE investors utilize fundamental indicators, such as Non Current Liabilities Total, to predict how Valneva Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Liabilities Total204.2 M214.4 M

Pair Trading with Valneva SE

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Valneva SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will appreciate offsetting losses from the drop in the long position's value.

Moving together with Valneva Stock

  0.69EQ EquilliumPairCorr
  0.67KG KING PHARMACEUTICALS INC Symbol ChangePairCorr
  0.79DMAC DiaMedica TherapeuticsPairCorr

Moving against Valneva Stock

  0.72DRMA Dermata TherapeuticsPairCorr
  0.65VCEL Vericel Corp OrdPairCorr
  0.36SABSW SAB BiotherapeuticsPairCorr
  0.32DVAX Dynavax TechnologiesPairCorr
The ability to find closely correlated positions to Valneva SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Valneva SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Valneva SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Valneva SE ADR to buy it.
The correlation of Valneva SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Valneva SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Valneva SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Valneva SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Valneva Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Valneva Se Adr Stock:
Check out the analysis of Valneva SE Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.22)
Revenue Per Share
2.488
Quarterly Revenue Growth
0.27
Return On Assets
(0.07)
Return On Equity
(0.38)
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.